Skip to main content

Alcon, Inc. (ALC)

NYSE: ALC · IEX Real-Time Price · USD
85.24 1.88 (2.26%)
Dec 8, 2021 4:00 PM EST - Market closed
Market Cap41.78B
Revenue (ttm)8.08B
Net Income (ttm)332.00M
Shares Out490.10M
EPS (ttm)0.67
PE Ratio127.41
Forward PE33.33
Dividend$0.20 (0.23%)
Ex-Dividend Daten/a
Volume540,640
Open84.50
Previous Close83.36
Day's Range83.66 - 85.26
52-Week Range62.63 - 87.49
Beta0.49
AnalystsBuy
Price Target85.83 (+0.7%)
Earnings DateNov 9, 2021

About ALC

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR sur...

IndustryMedical Instruments & Supplies
Founded1945
CEODavid J. Endicott
Employees23,000
Stock ExchangeNYSE
Ticker SymbolALC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 25 analysts, the average rating for Alcon stock is "Buy." The 12-month stock price forecast is 85.83, which is an increase of 0.69% from the latest price.

Price Target
$85.83
(0.69% upside)
Analyst Consensus: Buy

News

Alcon (ALC) Surgical Arm Grows Amid Global Trade Disruption

Segment wise, within Alcon's (ALC) Surgical arm, the portfolio of advanced technology intraocular lenses is driving increased penetration rates of ATIOLs.

2 weeks ago - Zacks Investment Research

Alcon (ALC) Q3 Earnings Beat Estimates, Margin Improves

Alcon (ALC) records year-over-year growth across all sales categories in Surgical and Vision Care in Q3.

3 weeks ago - Zacks Investment Research

Alcon Big Winner in 2019 Divorce From Novartis

Since being spun off into a separate company in April 2019, Alcon Inc. ( ALC , Financial) shares have thrived while the stock of its former parent, Novartis AG ( NVS , Financial), has languished.

Other symbols:NVS
4 weeks ago - GuruFocus

Alcon Reports Third Quarter 2021 Results

GENEVA--(BUSINESS WIRE)--Alcon Reports Third Quarter 2021 Results

4 weeks ago - Business Wire

Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021

1 month ago - Business Wire

Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Po...

GENEVA--(BUSINESS WIRE)--Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio

1 month ago - Business Wire

Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs

1 month ago - Business Wire

Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care

GENEVA--(BUSINESS WIRE)--Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care

1 month ago - Business Wire

Alcon's (ALC) Robust Product Line, Market Rebound Aid Growth

In Presbyopia-correcting Intraocular Lens (PCIOLs), Alcon (ALC) currently leads the market with over 55% of global share and over 80% share in the United States.

2 months ago - Zacks Investment Research

Alcon Honored with FutureEdge 50 Award

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon Honored with FutureEdge 50 Award

2 months ago - Business Wire

Here's Why You Should Add Alcon Stock (ALC) to Your Portfolio

Investors continue to be optimistic about Alcon (ALC) backed by robust second-quarter performance and raised 2021 outlook.

2 months ago - Zacks Investment Research

4 Stocks to Keep a Watch on Amid Growing Optical Care Demand

Stocks like Alcon (ALC), National Vision (EYE), The Cooper Companies (COO) and EyePoint Pharmaceuticals (EYPT) are gaining momentum amid rising optical care demand.

Other symbols:COOEYEEYPT
3 months ago - Zacks Investment Research

Alcon reports strong second-quarter results and positive long term outlook

David Endicott, CEO at Alcon, discusses second-quarter earnings.

3 months ago - CNBC International TV

Alcon (ALC) Q2 Earnings Top Estimates, 2021 Guidance Up

Alcon (ALC) records the highest sales in the second quarter of 2021 since its spin-off.

3 months ago - Zacks Investment Research

Investors Cheer Alcon's Updated Annual Guidance

Alcon AG (NYSE: ALC) reported second-quarter FY21 sales of $2.1 billion, +75% Y/Y on a reported basis and +69% on a constant currency basis, beating the consensus of $1.96 billion. All categories benefi...

3 months ago - Benzinga

Alcon Reports Second Quarter 2021 Results

GENEVA--(BUSINESS WIRE)--Alcon Reports Second Quarter 2021 Results

3 months ago - Business Wire

Alcon (ALC) to Report Q2 Earnings: What's in the Cards?

Continued strength in the Surgical segment and new launches under Vision Care segment are likely to have driven growth in the second quarter for Alcon (ALC).

3 months ago - Zacks Investment Research

Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens

GENEVA--(BUSINESS WIRE)--Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens

3 months ago - Business Wire

3 Medical Instruments Stocks Countering Industry Headwinds

The Zacks Medical - Instruments industry is growing on base business recovery. ISRG, IDXX and ALC are set to gain the most.

Other symbols:IDXXISRG
4 months ago - Zacks Investment Research

Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presenc...

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021

4 months ago - Business Wire

Reposition your portfolio for dividend yields, says Ariel's Bhansali

Rupal Bhansali, Ariel International Fund & Ariel Global Fund portfolio manager, discusses her approach to investing right now as well as her top picks for the second half of the year.

Other symbols:GEGSK
5 months ago - CNBC Television

Alcon Announces Executive Committee Changes

GENEVA--(BUSINESS WIRE)--Alcon Announces Executive Committee Changes

5 months ago - Business Wire

Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, ...

GENEVA--(BUSINESS WIRE)--Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021

6 months ago - Business Wire

Alcon Reports First Quarter 2021 Results

GENEVA--(BUSINESS WIRE)--Alcon Reports First Quarter 2021 Results

7 months ago - Business Wire

Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza

GENEVA--(BUSINESS WIRE)--Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza

7 months ago - Business Wire